United States Pharmaceuticals

Johnson & Johnson (JNJ)

Track

Track

Johnson & Johnson executives offloaded over $121 million in stock during the past quarter. CEO Joaquin Duato led these divestments, coinciding with a 19.7% share price increase. Following a positive earnings report, these fifteen transactions reflect significant selling activity by leadership, despite no recorded open-market purchases by insiders during this period.
Ticker: JNJ Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Johnson & Johnson. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.6
Taubert Jennifer L EVP, WWC. Innovative Medicine Officer
Transaction date
Sale
Price
421.38
Quantity 39,805 -49.5%
Value US$4,986,070
2.6
Taubert Jennifer L Officer Officer
Transaction date
Proposed sale
Price
180.11
Quantity 72,124
Value US$2,025,904
2.0
Duato Joaquin CEO and Chairman of the Board Executive Director
Transaction date
Sale
Price
349.34
Quantity 77,541 +13.5%
Value US$3,813,405
2.0
Duato Joaquin CEO and Chairman of the Board Executive Director
Transaction date
Sale
Price
262.00
Quantity 1,000 -5.3%
Value US$100,000
2.0
Duato Joaquin Officer; Director Executive Director
Transaction date
Proposed sale
Price
261.17
Quantity 1,000
Value US$100,000
Forminard Elizabeth EVP, Chief Legal Officer Officer
Transaction date
Sale
Price
255.93
Quantity 6,574 -27.9%
Value US$1,682,497
Forminard Elizabeth EVP, Chief Legal Officer Officer
Transaction date
Sale
Price
257.76
Quantity 9,344 -28.4%
Value US$2,408,463
Forminard Elizabeth Officer Officer
Transaction date
Proposed sale
Price
257.00
Quantity 15,918
Value US$4,090,957
2.0
Duato Joaquin CEO and Chairman of the Board Executive Director
Transaction date
Sale
Price
258.74
Quantity 6,523 -2.3%
Value US$1,687,754
2.0
Duato Joaquin CEO and Chairman of the Board Executive Director
Transaction date
Sale
Price
258.06
Quantity 41,957 -12.9%
Value US$10,827,256
2.0
Joaquin Duato CEO, Chariman
Transaction date
Proposed sale
Price
254.93
Quantity 48,480
Value US$12,359,006
2.9
Broadhurst Vanessa EVP, Global Corp Affairs Officer
Transaction date
Sale
Price
251.27
Quantity 23,054 -50.1%
Value US$5,792,686
2.9
Broadhurst Vanessa Officer Officer
Transaction date
Proposed sale
Price
251.27
Quantity 23,054
Value US$5,792,689
3.0
Wengel Kathryn E EVP, Chief TO and Risk Officer Officer
Transaction date
Sale
Price
241.15
Quantity 10,000 -8.0%
Value US$2,411,500
3.0
Wengel Kathryn E Officer Officer
Transaction date
Proposed sale
Price
240.15
Quantity 10,000
Value US$2,401,539
3.3
Decker Robert J VP Corporate Controller Officer
Transaction date
Sale
Price
247.87
Quantity 4,075 -14.7%
Value US$1,010,070
3.3
Decker Robert J Officer Officer
Transaction date
Proposed sale
Price
247.87
Quantity 4,075
Value US$1,010,070
3.3
Schmid Timothy EVP, WW Chair, MedTech Officer
Transaction date
Sale
Price
245.66
Quantity 1,322 -4.9%
Value US$324,763
3.3
Schmid Timothy Officer Officer
Transaction date
Proposed sale
Price
245.66
Quantity 1,322
Value US$324,763
3.3
Schmid Timothy EVP, WW Chair, MedTech Officer
Transaction date
Sale
Price
244.53
Quantity 8,998 -25.2%
Value US$2,200,281
3.3
Schmid Timothy EVP, WW Chair, MedTech Officer
Transaction date
Sale
Price
244.20
Quantity 13,625 -33.7%
Value US$3,327,225
3.3
Schmid Timothy Officer Officer
Transaction date
Proposed sale
Price
244.33
Quantity 22,623
Value US$5,527,546
2.6
REED JOHN C EVP, Innovative Medicine, R&D Officer
Transaction date
Sale
Price
243.00
Quantity 2,283 -17.6%
Value US$554,769
2.6
REED JOHN C EVP, Innovative Medicine, R&D Officer
Transaction date
Sale
Price
243.00
Quantity 29,927 -69.8%
Value US$7,272,261
2.6
REED JOHN C EVP, Innovative Medicine, R&D Officer
Transaction date
Sale
Price
243.00
Quantity 21,721 -62.7%
Value US$5,278,203
3.2
Wolk Joseph J Exec VP, CFO Officer
Transaction date
Sale
Price
242.68
Quantity 24,961 -64.1%
Value US$6,057,535
3.2
Wolk Joseph J Exec VP, CFO Officer
Transaction date
Sale
Price
242.75
Quantity 33,386 -46.1%
Value US$8,104,452
3.2
Wolk Joseph J Exec VP, CFO Officer
Transaction date
Sale
Price
242.87
Quantity 12,066 -23.6%
Value US$2,930,469
3.2
Wolk Joseph J Exec VP, CFO Officer
Transaction date
Sale
Price
242.99
Quantity 19,241 -33.1%
Value US$4,675,371
2.8
Swanson James D. EVP, CIO Officer
Transaction date
Sale
Price
242.70
Quantity 20,521 -44.4%
Value US$4,980,447
2.9
Broadhurst Vanessa EVP, Global Corp Affairs Officer
Transaction date
Sale
Price
243.39
Quantity 6,197 -21.2%
Value US$1,508,288
2.9
Broadhurst Vanessa Officer Officer
Transaction date
Proposed sale
Price
243.39
Quantity 6,197
Value US$1,508,300
2.8
Swanson James D. Officer Officer
Transaction date
Proposed sale
Price
242.70
Quantity 20,521
Value US$4,980,510
3.2
Wolk Joseph J Officer Officer
Transaction date
Proposed sale
Price
242.80
Quantity 89,654
Value US$21,767,965
2.6
REED JOHN C Officer Officer
Transaction date
Proposed sale
Price
243.00
Quantity 53,931
Value US$13,105,233
2.8
Swanson James D. EVP, CIO Officer
Transaction date
Sale
Price
243.71
Quantity 22,191 -47.0%
Value US$5,408,169
2.8
Swanson James D. EVP, CIO Officer
Transaction date
Sale
Price
243.76
Quantity 19,368 -43.6%
Value US$4,721,144
2.8
Swanson James D. Officer Officer
Transaction date
Proposed sale
Price
243.73
Quantity 41,559
Value US$10,129,246
Forminard Elizabeth Officer Officer
Transaction date
Proposed sale
Price
237.90
Quantity 6,226
Value US$1,481,195
2.0
Duato Joaquin CEO and Chairman of the Board Executive Director
Transaction date
Sale
Price
221.48
Quantity 48,782 -61.3%
Value US$10,804,432
2.0
Duato Joaquin CEO and Chairman of the Board Executive Director
Transaction date
Sale
Price
220.99
Quantity 51,218 -39.1%
Value US$11,318,461
2.0
Joaquin Duato CEO, Chariman
Transaction date
Proposed sale
Price
220.14
Quantity 100,000
Value US$22,014,000
2.7
MORIKIS JOHN G Non-Executive Director
Transaction date
Purchase
Price
206.15
Quantity 1,250 +208.9%
Value US$257,688
2.6
REED JOHN C EVP, Innovative Medicine, R&D Officer
Transaction date
Sale
Price
192.71
Quantity 21,721 -67.1%
Value US$4,185,793
2.6
REED JOHN C Officer Officer
Transaction date
Proposed sale
Price
192.71
Quantity 21,721
Value US$4,185,794
2.6
Taubert Jennifer L EVP, WWC. Innovative Medicine Officer
Transaction date
Sale
Price
177.81
Quantity 56,471 -24.1%
Value US$10,040,883
2.6
Taubert Jennifer L Officer Officer
Transaction date
Proposed sale
Price
177.81
Quantity 56,471
Value US$10,040,904
Forminard Elizabeth Officer Officer
Transaction date
Proposed sale
Price
177.20
Quantity 9,570
Value US$1,695,806
2.0
Duato Joaquin CEO and Chairman of the Board Executive Director
Transaction date
Sale
Price
179.21
Quantity 125,824 -31.3%
Value US$22,548,655
2.0
Duato Joaquin Officer; Director Executive Director
Transaction date
Proposed sale
Price
180.04
Quantity 125,824
Value US$22,652,724
3.2
Wolk Joseph J Exec VP, CFO Officer
Transaction date
Sale
Price
176.91
Quantity 16,820 -54.6%
Value US$2,975,571
3.2
Wolk Joseph J Officer Officer
Transaction date
Proposed sale
Price
176.91
Quantity 16,820
Value US$2,975,571
2.6
REED JOHN C EVP, Innovative Medicine, R&D Officer
Transaction date
Sale
Price
163.55
Quantity 19,137 -64.2%
Value US$3,129,830
2.6
REED JOHN C Officer Officer
Transaction date
Proposed sale
Price
163.55
Quantity 19,137
Value US$3,129,831
3.3
Decker Robert J VP Corporate Controller Officer
Transaction date
Sale
Price
165.88
Quantity 6,999 -25.0%
Value US$1,160,994
3.3
Decker Robert J Officer Officer
Transaction date
Proposed sale
Price
165.88
Quantity 6,999
Value US$1,161,010
3.3
Schmid Timothy EVP, WW Chair, MedTech Officer
Transaction date
Sale
Price
156.15
Quantity 403 -2.6%
Value US$62,928
3.2
Wolk Joseph J Exec VP, CFO Officer
Transaction date
Sale
Price
153.89
Quantity 13,015 -100.0%
Value US$2,002,878
3.2
Wolk Joseph J Officer Officer
Transaction date
Proposed sale
Price
153.89
Quantity 13,015
Value US$2,002,924
2.2
WEINBERGER MARK A Non-Executive Director
Transaction date
Purchase
Price
147.22
Quantity 1,000 +inf%
Value US$147,220
3.4
Hait William Former Officer Officer
Transaction date
Proposed sale
Price
149.90
Quantity 25,742
Value US$3,858,598
3.3
Decker Robert J VP Corporate Controller Officer
Transaction date
Sale
Price
165.06
Quantity 5,635 -22.9%
Value US$930,113
3.3
Decker Robert J Officer Officer
Transaction date
Proposed sale
Price
165.06
Quantity 5,635
Value US$930,113
2.9
VANESSA BROADHURST Officer Officer
Transaction date
Proposed sale
Price
162.16
Quantity 8,891
Value US$1,441,732
2.9
Broadhurst Vanessa EVP, Global Corp Affairs Officer
Transaction date
Sale
Price
162.16
Quantity 8,891 -37.1%
Value US$1,441,765
2.6
Taubert Jennifer L EVP, WW Chair, Pharmaceuticals Officer
Transaction date
Sale
Price
156.27
Quantity 59,397 -29.6%
Value US$9,281,969
2.9
McEvoy Ashley Former Officer Officer
Transaction date
Proposed sale
Price
156.50
Quantity 24,613
Value US$3,851,866
2.6
Taubert Jennifer L Officer Officer
Transaction date
Proposed sale
Price
156.25
Quantity 59,397
Value US$9,280,528
2.9
McEvoy Ashley FORMER OFFICER Officer
Transaction date
Proposed sale
Price
157.88
Quantity 24,612
Value US$3,885,716
3.4
Hait William See Remarks Officer
Transaction date
Sale
Price
172.00
Quantity 14,698 -14.3%
Value US$2,528,056
3.4
Hait William Officer Officer
Transaction date
Proposed sale
Price
172.00
Quantity 14,698
Value US$2,528,056
2.6
Fasolo Peter Exec VP, Chief HR Officer Officer
Transaction date
Sale
Price
170.32
Quantity 20,000 -16.3%
Value US$3,406,498
2.6
Fasolo Peter Officer Officer
Transaction date
Proposed sale
Price
170.28
Quantity 20,000
Value US$3,405,662
3.0
Wengel Kathryn E EVP, Chief TO and Risk Officer Officer
Transaction date
Sale
Price
160.00
Quantity 12,465 -15.9%
Value US$1,994,400
3.0
Wengel Kathryn E Officer Officer
Transaction date
Proposed sale
Price
160.00
Quantity 12,465
Value US$1,994,400
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-18 2026-08-17 S Sale
2.6
Taubert Jennifer L

EVP, WWC. Innovative Medicine

Officer
39,805 -49.5%
421.38
US$4,986,070 		39,805 -49.5% 421.38 US$4,986,070
2026-08-17 2026-08-17 PrS Proposed sale
2.6
Taubert Jennifer L

Officer

Officer
72,124
180.11
US$2,025,904 		72,124 180.11 US$2,025,904
2026-08-14 2026-08-13 S Sale
2.0
Duato Joaquin

CEO and Chairman of the Board

Executive Director
77,541 +13.5%
349.34
US$3,813,405 		77,541 +13.5% 349.34 US$3,813,405
2026-08-14 2026-08-13 S Sale
2.0
Duato Joaquin

CEO and Chairman of the Board

Executive Director
1,000 -5.3%
262.00
US$100,000 		1,000 -5.3% 262.00 US$100,000
2026-08-13 2026-08-13 PrS Proposed sale
2.0
Duato Joaquin

Officer; Director

Executive Director
1,000
261.17
US$100,000 		1,000 261.17 US$100,000
2026-08-07 2026-08-06 S Sale
Forminard Elizabeth

EVP, Chief Legal Officer

Officer
6,574 -27.9%
255.93
US$1,682,497 		6,574 -27.9% 255.93 US$1,682,497
2026-08-07 2026-08-06 S Sale
Forminard Elizabeth

EVP, Chief Legal Officer

Officer
9,344 -28.4%
257.76
US$2,408,463 		9,344 -28.4% 257.76 US$2,408,463
2026-08-06 2026-08-06 PrS Proposed sale
Forminard Elizabeth

Officer

Officer
15,918
257.00
US$4,090,957 		15,918 257.00 US$4,090,957
2026-08-07 2026-08-05 S Sale
2.0
Duato Joaquin

CEO and Chairman of the Board

Executive Director
6,523 -2.3%
258.74
US$1,687,754 		6,523 -2.3% 258.74 US$1,687,754
2026-08-07 2026-08-05 S Sale
2.0
Duato Joaquin

CEO and Chairman of the Board

Executive Director
41,957 -12.9%
258.06
US$10,827,256 		41,957 -12.9% 258.06 US$10,827,256
2026-08-05 2026-08-05 PrS Proposed sale
2.0
Joaquin Duato

CEO, Chariman
48,480
254.93
US$12,359,006 		48,480 254.93 US$12,359,006
2026-07-21 2026-07-20 S Sale
2.9
Broadhurst Vanessa

EVP, Global Corp Affairs

Officer
23,054 -50.1%
251.27
US$5,792,686 		23,054 -50.1% 251.27 US$5,792,686
2026-07-20 2026-07-20 PrS Proposed sale
2.9
Broadhurst Vanessa

Officer

Officer
23,054
251.27
US$5,792,689 		23,054 251.27 US$5,792,689
2026-06-12 2026-06-11 S Sale
3.0
Wengel Kathryn E

EVP, Chief TO and Risk Officer

Officer
10,000 -8.0%
241.15
US$2,411,500 		10,000 -8.0% 241.15 US$2,411,500
2026-06-11 2026-06-11 PrS Proposed sale
3.0
Wengel Kathryn E

Officer

Officer
10,000
240.15
US$2,401,539 		10,000 240.15 US$2,401,539
2026-03-03 2026-02-27 S Sale
3.3
Decker Robert J

VP Corporate Controller

Officer
4,075 -14.7%
247.87
US$1,010,070 		4,075 -14.7% 247.87 US$1,010,070
2026-02-27 2026-02-27 PrS Proposed sale
3.3
Decker Robert J

Officer

Officer
4,075
247.87
US$1,010,070 		4,075 247.87 US$1,010,070
2026-02-23 2026-02-20 S Sale
3.3
Schmid Timothy

EVP, WW Chair, MedTech

Officer
1,322 -4.9%
245.66
US$324,763 		1,322 -4.9% 245.66 US$324,763
2026-02-20 2026-02-20 PrS Proposed sale
3.3
Schmid Timothy

Officer

Officer
1,322
245.66
US$324,763 		1,322 245.66 US$324,763
2026-02-18 2026-02-18 S Sale
3.3
Schmid Timothy

EVP, WW Chair, MedTech

Officer
8,998 -25.2%
244.53
US$2,200,281 		8,998 -25.2% 244.53 US$2,200,281
2026-02-18 2026-02-18 S Sale
3.3
Schmid Timothy

EVP, WW Chair, MedTech

Officer
13,625 -33.7%
244.20
US$3,327,225 		13,625 -33.7% 244.20 US$3,327,225
2026-02-18 2026-02-18 PrS Proposed sale
3.3
Schmid Timothy

Officer

Officer
22,623
244.33
US$5,527,546 		22,623 244.33 US$5,527,546
2026-02-18 2026-02-17 S Sale
2.6
REED JOHN C

EVP, Innovative Medicine, R&D

Officer
2,283 -17.6%
243.00
US$554,769 		2,283 -17.6% 243.00 US$554,769
2026-02-18 2026-02-17 S Sale
2.6
REED JOHN C

EVP, Innovative Medicine, R&D

Officer
29,927 -69.8%
243.00
US$7,272,261 		29,927 -69.8% 243.00 US$7,272,261
2026-02-18 2026-02-17 S Sale
2.6
REED JOHN C

EVP, Innovative Medicine, R&D

Officer
21,721 -62.7%
243.00
US$5,278,203 		21,721 -62.7% 243.00 US$5,278,203
2026-02-18 2026-02-17 S Sale
3.2
Wolk Joseph J

Exec VP, CFO

Officer
24,961 -64.1%
242.68
US$6,057,535 		24,961 -64.1% 242.68 US$6,057,535
2026-02-18 2026-02-17 S Sale
3.2
Wolk Joseph J

Exec VP, CFO

Officer
33,386 -46.1%
242.75
US$8,104,452 		33,386 -46.1% 242.75 US$8,104,452
2026-02-18 2026-02-17 S Sale
3.2
Wolk Joseph J

Exec VP, CFO

Officer
12,066 -23.6%
242.87
US$2,930,469 		12,066 -23.6% 242.87 US$2,930,469
2026-02-18 2026-02-17 S Sale
3.2
Wolk Joseph J

Exec VP, CFO

Officer
19,241 -33.1%
242.99
US$4,675,371 		19,241 -33.1% 242.99 US$4,675,371
2026-02-18 2026-02-17 S Sale
2.8
Swanson James D.

EVP, CIO

Officer
20,521 -44.4%
242.70
US$4,980,447 		20,521 -44.4% 242.70 US$4,980,447
2026-02-18 2026-02-17 S Sale
2.9
Broadhurst Vanessa

EVP, Global Corp Affairs

Officer
6,197 -21.2%
243.39
US$1,508,288 		6,197 -21.2% 243.39 US$1,508,288
2026-02-17 2026-02-17 PrS Proposed sale
2.9
Broadhurst Vanessa

Officer

Officer
6,197
243.39
US$1,508,300 		6,197 243.39 US$1,508,300
2026-02-17 2026-02-17 PrS Proposed sale
2.8
Swanson James D.

Officer

Officer
20,521
242.70
US$4,980,510 		20,521 242.70 US$4,980,510
2026-02-17 2026-02-17 PrS Proposed sale
3.2
Wolk Joseph J

Officer

Officer
89,654
242.80
US$21,767,965 		89,654 242.80 US$21,767,965
2026-02-17 2026-02-17 PrS Proposed sale
2.6
REED JOHN C

Officer

Officer
53,931
243.00
US$13,105,233 		53,931 243.00 US$13,105,233
2026-02-18 2026-02-13 S Sale
2.8
Swanson James D.

EVP, CIO

Officer
22,191 -47.0%
243.71
US$5,408,169 		22,191 -47.0% 243.71 US$5,408,169
2026-02-18 2026-02-13 S Sale
2.8
Swanson James D.

EVP, CIO

Officer
19,368 -43.6%
243.76
US$4,721,144 		19,368 -43.6% 243.76 US$4,721,144
2026-02-13 2026-02-13 PrS Proposed sale
2.8
Swanson James D.

Officer

Officer
41,559
243.73
US$10,129,246 		41,559 243.73 US$10,129,246
2026-02-05 2026-02-05 PrS Proposed sale
Forminard Elizabeth

Officer

Officer
6,226
237.90
US$1,481,195 		6,226 237.90 US$1,481,195
2026-01-28 2026-01-26 S Sale
2.0
Duato Joaquin

CEO and Chairman of the Board

Executive Director
48,782 -61.3%
221.48
US$10,804,432 		48,782 -61.3% 221.48 US$10,804,432
2026-01-28 2026-01-26 S Sale
2.0
Duato Joaquin

CEO and Chairman of the Board

Executive Director
51,218 -39.1%
220.99
US$11,318,461 		51,218 -39.1% 220.99 US$11,318,461
2026-01-26 2026-01-26 PrS Proposed sale
2.0
Joaquin Duato

CEO, Chariman
100,000
220.14
US$22,014,000 		100,000 220.14 US$22,014,000
2025-12-01 2025-11-26 B Purchase
2.7
MORIKIS JOHN G
Non-Executive Director
1,250 +208.9%
206.15
US$257,688 		1,250 +208.9% 206.15 US$257,688
2025-10-20 2025-10-17 S Sale
2.6
REED JOHN C

EVP, Innovative Medicine, R&D

Officer
21,721 -67.1%
192.71
US$4,185,793 		21,721 -67.1% 192.71 US$4,185,793
2025-10-17 2025-10-17 PrS Proposed sale
2.6
REED JOHN C

Officer

Officer
21,721
192.71
US$4,185,794 		21,721 192.71 US$4,185,794
2025-09-05 2025-09-04 S Sale
2.6
Taubert Jennifer L

EVP, WWC. Innovative Medicine

Officer
56,471 -24.1%
177.81
US$10,040,883 		56,471 -24.1% 177.81 US$10,040,883
2025-09-04 2025-09-04 PrS Proposed sale
2.6
Taubert Jennifer L

Officer

Officer
56,471
177.81
US$10,040,904 		56,471 177.81 US$10,040,904
2025-08-29 2025-08-29 PrS Proposed sale
Forminard Elizabeth

Officer

Officer
9,570
177.20
US$1,695,806 		9,570 177.20 US$1,695,806
2025-08-25 2025-08-22 S Sale
2.0
Duato Joaquin

CEO and Chairman of the Board

Executive Director
125,824 -31.3%
179.21
US$22,548,655 		125,824 -31.3% 179.21 US$22,548,655
2025-08-22 2025-08-22 PrS Proposed sale
2.0
Duato Joaquin

Officer; Director

Executive Director
125,824
180.04
US$22,652,724 		125,824 180.04 US$22,652,724
2025-08-18 2025-08-15 S Sale
3.2
Wolk Joseph J

Exec VP, CFO

Officer
16,820 -54.6%
176.91
US$2,975,571 		16,820 -54.6% 176.91 US$2,975,571
2025-08-15 2025-08-15 PrS Proposed sale
3.2
Wolk Joseph J

Officer

Officer
16,820
176.91
US$2,975,571 		16,820 176.91 US$2,975,571
2025-07-18 2025-07-17 S Sale
2.6
REED JOHN C

EVP, Innovative Medicine, R&D

Officer
19,137 -64.2%
163.55
US$3,129,830 		19,137 -64.2% 163.55 US$3,129,830
2025-07-17 2025-07-17 PrS Proposed sale
2.6
REED JOHN C

Officer

Officer
19,137
163.55
US$3,129,831 		19,137 163.55 US$3,129,831
2025-02-26 2025-02-25 S Sale
3.3
Decker Robert J

VP Corporate Controller

Officer
6,999 -25.0%
165.88
US$1,160,994 		6,999 -25.0% 165.88 US$1,160,994
2025-02-25 2025-02-25 PrS Proposed sale
3.3
Decker Robert J

Officer

Officer
6,999
165.88
US$1,161,010 		6,999 165.88 US$1,161,010
2025-02-18 2025-02-18 S Sale
3.3
Schmid Timothy

EVP, WW Chair, MedTech

Officer
403 -2.6%
156.15
US$62,928 		403 -2.6% 156.15 US$62,928
2025-02-11 2025-02-07 S Sale
3.2
Wolk Joseph J

Exec VP, CFO

Officer
13,015 -100.0%
153.89
US$2,002,878 		13,015 -100.0% 153.89 US$2,002,878
2025-02-07 2025-02-07 PrS Proposed sale
3.2
Wolk Joseph J

Officer

Officer
13,015
153.89
US$2,002,924 		13,015 153.89 US$2,002,924
2024-12-12 2024-12-12 B Purchase
2.2
WEINBERGER MARK A
Non-Executive Director
1,000 +inf%
147.22
US$147,220 		1,000 +inf% 147.22 US$147,220
2024-12-04 2024-12-04 PrS Proposed sale
3.4
Hait William

Former Officer

Officer
25,742
149.90
US$3,858,598 		25,742 149.90 US$3,858,598
2024-09-03 2024-08-30 S Sale
3.3
Decker Robert J

VP Corporate Controller

Officer
5,635 -22.9%
165.06
US$930,113 		5,635 -22.9% 165.06 US$930,113
2024-08-30 2024-08-30 PrS Proposed sale
3.3
Decker Robert J

Officer

Officer
5,635
165.06
US$930,113 		5,635 165.06 US$930,113
2024-03-13 2024-03-13 PrS Proposed sale
2.9
VANESSA BROADHURST

Officer

Officer
8,891
162.16
US$1,441,732 		8,891 162.16 US$1,441,732
2024-03-13 2024-03-13 S Sale
2.9
Broadhurst Vanessa

EVP, Global Corp Affairs

Officer
8,891 -37.1%
162.16
US$1,441,765 		8,891 -37.1% 162.16 US$1,441,765
2024-02-12 2024-02-09 S Sale
2.6
Taubert Jennifer L

EVP, WW Chair, Pharmaceuticals

Officer
59,397 -29.6%
156.27
US$9,281,969 		59,397 -29.6% 156.27 US$9,281,969
2024-02-09 2024-02-09 PrS Proposed sale
2.9
McEvoy Ashley

Former Officer

Officer
24,613
156.50
US$3,851,866 		24,613 156.50 US$3,851,866
2024-02-09 2024-02-09 PrS Proposed sale
2.6
Taubert Jennifer L

Officer

Officer
59,397
156.25
US$9,280,528 		59,397 156.25 US$9,280,528
2024-02-06 2024-02-06 PrS Proposed sale
2.9
McEvoy Ashley

FORMER OFFICER

Officer
24,612
157.88
US$3,885,716 		24,612 157.88 US$3,885,716
2023-07-27 2023-07-26 S Sale
3.4
Hait William

See Remarks

Officer
14,698 -14.3%
172.00
US$2,528,056 		14,698 -14.3% 172.00 US$2,528,056
2023-07-26 2023-07-26 PrS Proposed sale
3.4
Hait William

Officer

Officer
14,698
172.00
US$2,528,056 		14,698 172.00 US$2,528,056
2023-07-27 2023-07-25 S Sale
2.6
Fasolo Peter

Exec VP, Chief HR Officer

Officer
20,000 -16.3%
170.32
US$3,406,498 		20,000 -16.3% 170.32 US$3,406,498
2023-07-25 2023-07-25 PrS Proposed sale
2.6
Fasolo Peter

Officer

Officer
20,000
170.28
US$3,405,662 		20,000 170.28 US$3,405,662
2023-06-14 2023-06-12 S Sale
3.0
Wengel Kathryn E

EVP, Chief TO and Risk Officer

Officer
12,465 -15.9%
160.00
US$1,994,400 		12,465 -15.9% 160.00 US$1,994,400
2023-06-12 2023-06-12 PrS Proposed sale
3.0
Wengel Kathryn E

Officer

Officer
12,465
160.00
US$1,994,400 		12,465 160.00 US$1,994,400
Explore more

More insider trading research around Johnson & Johnson

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America
Insider trades in S&P 500